Joseph Schlessinger
William H. Prusoff Professor and Chairman of the Pharmacology Department, Yale School of Medicine; Director, Yale Cancer Biology Institute
False
Advertisement
Meet Joseph Schlessinger
“The focus of my research during the past 12 months has been the identification of the ligand for the orphan receptor tyrosine kinase (RTK) ALK, and elucidation of the mechanism of action of a therapeutic antibody using structural and biochemical studies, as well as exploration of signaling pathways that are aberrantly activated by oncogenic RTKs in cancer,” says Joseph.
False
Advertisement